Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1

Diabetes

Volumn 51, Issue 10, 2002, Pages 2922-2928

  Uehara, Yoshinari ^a,b,c   Engel, Thomas ^b   Li, Zhengchen ^b   Goepfert, Christian ^a   Rust, Stephan ^b   Zhou, Xiaoqin ^b   Langer, Claus ^b   Schachtrup, Christian ^a   Wiekowski, Johannes ^b   Lorkowski, Stefan ^b   Assmann, Gerd ^a,b   Von Eckardstein, Arnold ^a,b,c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Inst of Arteriosclerosis Research   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ACETOACETIC ACID; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYBUTYRIC ACID; INSULIN; LUCIFERASE; MESSENGER RNA; OXYSTEROL; POLYUNSATURATED FATTY ACID; RETINOIC ACID; RETINOID X RECEPTOR; SATURATED FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL LINE; CELL STRAIN HEPG2; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; GENE CONSTRUCT; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER; LIVER CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR;

EID: 0036789676     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.10.2922     Document Type: Article

References (45)

1. von Eckardstein A, Nofer JR, Assmann G: HDL and coronary heart disease: role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 20:13-27, 2001
2. Després JP, Marette A: Relation of components of insulin resistance to coronary disease risk. Curr Opin Lipidol 5:274-289, 1994
3. Hergenc G, Schulte H, Assmann G, von Eckardstein A: Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals. Atherosclerosis 145:147-156, 1999
4. Karhapää P, Malkki M. Laakso M: Isolated low HDL cholesterol: an insulin-resistant state. Diabetes 43:411-417, 1994
5. von Eckardstein A, Schulte H, Assmann G: Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. J Clin Endocrinol Metab 85:3101-3108, 2000
6. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HOF, Loubser O, Ouelette BFF, Fichter K, Ashbourne-Excoffon KJD, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJP, Genest J, Hayden MR: Mutations in ABCA1 in Tangier disease and familial high density lipoprotein deficiency. Nat Genet 22:336-345, 1999
7. Bodzioch M, Orso E, Klucken J, Langmann T, Böttcher A, Diedrich W, Drobnik W, Barlage S, Büchler C, Porsch-Özcürümez M, Kaminski W, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G: The gene encoding ATP binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347-351, 1999
8. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefie P, Assmann G: Tangier disease is caused by mutations in the gene encoding ATP binding cassette transporter 1. Nat Genet 22:352-255, 1999
9. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, Oram JF: The Tangier disease gene product control subjects: the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104: R25-R31, 1999
10. Assmann G, von Eckardstein A, Brewer HB Jr: Familial analphalipoproteinemia: Tangier disease. In The Metabolic and Molecular Bases of Inherited Disease. 8th Ed. Scriver, Beaudet, Sly, Valle, Eds. New York, McGraw-Hill, 2000, p. 2937-2960
11. Oram JF, Lawn RM, Garver MR, Wade DP: ABCA1 is the 8-Br-cAMP-inducible receptor that mediates cholesterol secretion from macrophages. J Biol Chem 275:34508-34511, 2000
12. Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, Tontonoz P: Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A 97:12097-12102, 2000
13. Costet P, Luo Y, Wang N, Tall AR: Sterol-dependent transactivation of the ABC1 pomoter by LXR/RXR: LXRs transactivate ABC1 promotor. J Biol Chem 275:28240-28245, 2000
14. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ: Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529, 2000
15. Panousis CG, Zuckerman SH: Interferon-γ induces downregulation of Tangier disease gene (ATP binding cassette transporter 1) in macrophage-derived foam cells. Arterioscler Thromb Vasc Biol 20:156.5-1571, 2000
16. von Eckardstein A, Funke H, Walter M, Altland K, Benninghoven K, Assmann G: Structural analysis of apolipoprotein A-I variants: amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure. J Biol Chem 265:8610-8617, 1990
17. Lakshmanan MR, Nepokroeff CM, Porter JW: Control of the synthesis of fatty-acid synthetase in rat liver by insulin, glucagon, and adenosine 3′:5′ cyclic monophosphate. Proc Natl Acad Sci U S A 69:3516-3519, 1972
18. Santamarina-Fojo S, Peterson K, Knapper C, Qiu Y, Freeman L, Cheng JF, Osorio J, Remaley A, Yang XP, Haudenschild C, Prades C, Chimini G, Blackmon E, Francois T, Duverger N, Rubin EM, Rosier M, Denefle P, Fredrickson DS, Brewer HB Jr: Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc Natl Acad Sci USA 97:7987-7992, 2000
19. Wang Y, Oram JF: Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J Biol Chem 277:5692-5697, 2002
20. Chinetti, G. Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B: PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nature Medicine 7:53-58, 2001
21. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ: An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383:728-731, 1996
22. Tobin KA, Steineger HH, Alberti S, Spydevold O, Auwerx J, Gustafsson JA, Nebb HI: Cross-talk between fatty acid and cholesterol metabolism mediated by. liver X receptor-alpha. Mol Endocrinol 14:741-752, 2000
23. Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA, Bashmakov Y, Goldstein JL, Brown MS: Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci U S A 98:6027-6032, 2001
24. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, Tontonoz P: A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7:161-171, 2001
25. Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, Xu HE, Sternbach DD, Kliewer SA, Hansen BC, Willson TM: A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 98:5306-5311, 2001
26. Yoshikawa T, Shimano H, Yahagi N, Ide T, Amemiya-Kudo M, Matsuzaka T, Nakakuki M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Takahashi A, Sone H, Osuga Ji J, Gotoda T, Ishibashi S, Yamada N: Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 277:1705-1711, 2002
27. Grundy SM, Denke MA: Dietary influences on serum lipids and lipoproteins. J Lipid Res 31:1149-1172, 1990
28. Haas MJ, Pun K, Reinacher D, Wong NC, Mooradian AD: Effects of ketoacidosis on rat apolipoprotein A1 gene expression: a link with acidosis but not with ketones. J Mol Endocrinol 25:129-139, 2000
29. Laffel L: Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabete Metab Res Rev 15:412-426, 1999
30. Newsholme P, Gordon S, Newsholme EA: Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J 242:631-636, 1987
31. Jain SK, Kannan K, Lim G: Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic Biol Med 25:1083-1088, 1998
32. Kamata H, Hirata H: Redox regulation of cellular signalling. Cell Signal 11:1-14, 1999
33. Murao K, Wada Y, Nakamura T, Taylor AH, Mooradian AD, Wong NC: Effects of glucose and insulin on rat apolipoprotein A-I gene expression. J Biol Chem 273:18959-18965, 1998
34. Zheng XL, Matsubara S, Diao C, Hollenberg MD, Wong NC: Epidermal growth factor induction of apolipoprotein A-I is mediated by the Ras-MAP kinase cascade and Sp1. J Biol Chem 276:13822-13829, 2001
35. Foretz M, Guichard C, Ferre P, Foufelle F: Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A 96:12737-12742, 1999
36. Shimomura I, Bashmakov Y., Ikemoto S, Horton JD, Brown MS, Goldstein JL: Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96:13656-13661, 1999
37. Fried SK, Russell CD, Grauso NL, Brolin RE: Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 92:2191-2198, 1993
38. Strauss JG, Frank S, Kratky D, Hammerle G, Hrzenjak A, Knipping G, von Eckardstein A, Kostner GM, Zechner R: Adenovirus mediated rescue of lipoprotein lipase-deficient mice: lipolysis of triglyceride-rich lipoproteins is essential for HDL maturation in mice. J Biol Chem 276:36083-36090, 2001
39. Rye KA, Clay MA, Barter PJ: Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 145:227-238, 1999
40. Berthou L, Saladin R, Yaqoob P, Branellec D, Calder P, Fruchart JC, Denefle P, Auwerx J, Staels B: Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acyl-coenzyme A oxidase gene expression by fibrates and dietary fatty acids. Eur J Biochem 232:179-187, 1995
41. Hirano R, Igarashi O, Kondo K, Itakura H, Matsumoto A: Regulation by long-chain fatty acids of the expression of cholesteryl ester transfer protein in HepG2 cells. Lipids 36:401-406, 2001
42. Valabhji J, McColl AJ, Schachter M, Dhanjil S, Richmond W, Elkeles RS: High-density lipoprotein composition and paraoxonase activity in type I diabetes. Clin Sci (Lond) 101:659-670, 2001
43. Perez A, Wagner AM, Carreras G, Gimenez G, Sanchez-Quesada JL, Rigla M, Gomez-Gerique JA, Pou JM, de Leiva A: Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control. Arch Intern Med 160:2756-2762, 2000
44. Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH: Factors associated with plasma lipids and lipoproteins in type 1 diabetes: the EURODIAB IDDM Complications Study. Diabet Med 18:786-796, 2000
45. Mattock MB, Cronin N, Cavallo-Perin P, Idzior-Walus B, Penno G, Bandinelli S, Standl E, Kofinis A, Fuller JH: Plasma lipids and urinary albumin excretion rate in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med 18:59-67, 2001